Since 1998, CONET has conducted multinational and regional clinical trials for pharmaceutical, biotechnological and medical device companies, located in all ICH regions (European Union, USA and Japan). Through years of practical experience and co-operation, CONET has established good working relationships with opinion leaders and professional organizations. Our clients benefit from these relationships and gain an advantage by having access to a wider network of investigators and patient populations.
CONET has been involved in several clinical development programs and conducted successfully pivotal clinical trials especially in colorectal cancer and pulmonary arterial hypertension which resulted in European and US marketing authorizations.
In the following therapeutic areas, CONET offers broad study experiences and extensive knowledge in the implementation of best practices for clinical trials phase I-IV and medical device trials conducted all over Europe and Israel:
CONET’s long-term experience in large multi-national and regional cardiovascular clinical trials (phase 2 and 3) with more than 100 sites includes:
CONET offers broad experience in the fast growing therapeutic field of oncology:
CONET experts are also knowledgeable in psychiatric and neurologic indications as well as angina pectoris, myocardial infarction, renal anemia and various metabolic diseases such as hypercalcemia, hypercholesteremia and hypertriglyceridemia.
Pediatric clinical trials are different. From a medical point of view, children cannot just be seen as little adults. This patient population is more vulnerable and therefore needs special protection when participating in clinical research. CONET considers and understands the particular challenges of managing ethics and regulatory requirements for pediatric clinical trials. Safety is our biggest concern from the perspective of pediatric subjects, their families and the physicians who care for them.